Experimental findings in mice indicate that FGF21 mitigates hyperglycemia, in part, by reducing renal glucose reabsorption through the peroxisome proliferator-activated receptor-δ (PPARδ)-mediated sodium-glucose cotransporter 2 (SGLT2) pathway (45). Here, SLC5A2 is linked to Hyperglycemia.